By the Numbers: India’s Formula for GCC Success in Healthcare
With 300K+ professionals and 55+ major hubs, India's GCCs are using AI and next-gen tech to accelerate drug discovery and shape the future of global medicine.
Global Capability Centres (GCCs) in India have become assets for multinational corporations, positioning the country as a hub for innovation. This growth is fuelled by India’s distinct strengths including a large skilled workforce, advanced technological capabilities, a thriving startup ecosystem, and supportive government policies.
In the life sciences sector, Indian GCCs now play a key role across the entire drug development lifecycle — from research and development to manufacturing and commercialisation — while transforming clinical trials through digital platforms, blockchain-based data integrity, and AI-driven real-time monitoring.
